Imiquimod is a cream you put on your skin. It helps your body fight off certain types of skin infections, like warts caused by the human papillomavirus (HPV). It works by boosting your immune system's ability to fight these infections.
Every report comes from a Lived member, sent anonymously.
Have you tried Imiquimod for Genital Warts?
Imiquimod is a prescription cream that treats certain skin growths by stirring up the immune system in the skin where it is applied. In the US it comes as a generic 5% cream (originally sold as Aldara, a brand that is no longer marketed here) and as Zyclara, a lower-strength 2.5% or 3.75% cream. It is approved for three conditions in people whose immune systems work normally. The first is actinic keratosis: rough, scaly patches caused by years of sun exposure, usually on the face or scalp. They are not cancer, but some can develop into a skin cancer called squamous cell carcinoma, which is why they are often treated. Imiquimod is one of the main treatments dermatologists recommend, along with freezing (cryotherapy) and fluorouracil cream. A cream has the advantage of treating a whole area, including early patches too small to see. The second is superficial basal cell carcinoma, a shallow form of the most common skin cancer. Only the 5% cream is approved for this, and only for a small tumor (up to 2 cm across) on the trunk, neck, arms or legs that a biopsy has confirmed is the superficial type. Surgery remains the usual treatment; imiquimod is an option when surgery is less suitable and regular follow-up is possible. It is not approved for deeper types of basal cell carcinoma. The third is external genital and perianal warts, caused by human papillomavirus (HPV), in people 12 and older. Both the 5% cream and Zyclara 3.75% are used, and US sexually transmitted infection guidelines list imiquimod among the treatments people can apply themselves at home, alongside clinic options such as freezing or removal.
Immune cells carry sensors that detect signs of viral infection. Imiquimod activates one of these sensors, called toll-like receptor 7. The cells respond by releasing interferon and other signaling proteins that draw more immune cells into the treated skin. Those cells can then attack abnormal or virus-infected cells, which is why the cream works on warts even though it has no direct antiviral effect. The redness, crusting and swelling people see during treatment are largely this immune response at work. Researchers have measured these immune changes in treated skin, but exactly how they lead to a growth clearing is not fully understood, and the strength of the reaction varies from person to person.
Imiquimod is applied as a thin layer at bedtime, rubbed in until it disappears, left on for about 8 hours (6 to 10 hours for warts) and then washed off with mild soap and water. Wash your hands before and after, and let freshly washed skin dry for about 10 minutes before applying. It is for external skin only; keep it away from the eyes, lips and nostrils, and do not put it inside the vagina or anus. The schedule depends on the condition and the product, and it is not the same as most creams applied every day. With the 5% cream, actinic keratoses are treated twice a week for 16 weeks on one patch about 5 cm by 5 cm; superficial basal cell carcinoma five times a week for 6 weeks, covering the tumor plus about 1 cm of surrounding skin; and genital warts three times a week until they clear, for up to 16 weeks. Zyclara is used daily: for actinic keratoses, on the whole face or balding scalp for 2 weeks, then a 2-week break, then 2 more weeks; for genital warts (3.75% only), until they clear, for up to 8 weeks. Use only the amount prescribed, and throw away any cream left in an opened single-use packet. Do not cover the area with a bandage; loose cotton underwear or gauze is fine for genital warts. People with a foreskin who are treating warts underneath it should pull it back and clean the area daily. If you miss a dose, apply the next one at the usual time rather than doubling up.
Skin reactions in the treated area are expected and are part of how the cream works. Redness, flaking, crusting, swelling, itching and burning are very common, and many people develop raw spots, small blisters or weeping. The reaction can spread somewhat beyond where the cream was applied. Some people also feel flu-like, with tiredness, fever, chills, headache or muscle aches, sometimes before the skin reaction appears, and nearby lymph nodes can swell for a few weeks. A prescriber can approve a break of several days if the reaction becomes too uncomfortable, and washing the cream off promptly helps when a reaction is severe. Contact the care team promptly if the reaction is bad enough to interfere with daily activities or make it hard to keep applying the cream. Women treating warts near the vaginal opening can develop severe vulvar swelling that makes it difficult to pass urine; stop the cream and contact the care team right away if that happens. Less commonly, the treated skin loses its color. This lighter or white skin has lasted years in some people, so mention any new pale patch to the prescriber, who may stop treatment.
Very little imiquimod reaches the bloodstream, so interactions with medicines taken by mouth are not a recognized concern. The main cautions are about the skin. Do not use it on broken, burned or infected skin, and do not combine it with another imiquimod product on the same area, which makes reactions stronger. Imiquimod makes skin burn more easily in the sun: avoid sun exposure and tanning beds during treatment, use sunscreen and a hat, and wait until any sunburn has fully healed before applying it. For genital warts, the cream can weaken condoms and diaphragms, so they cannot be relied on while it is in use. Avoid genital, anal and oral sexual contact while the cream is on the skin. Treatment removes visible warts but does not cure the underlying HPV infection, and it is not known to stop transmission to partners. Because it activates the immune system, imiquimod can trigger flares of inflammatory or autoimmune skin conditions, such as psoriasis, vitiligo or lichen planus, and of chronic graft-versus-host disease after a transplant. People with these conditions should discuss them before starting. Its approvals are for people with normally working immune systems, so anyone with a weakened immune system should ask how well it is likely to work. Research in human pregnancy is limited. Reports so far have not shown a higher risk of birth defects, but US guidelines suggest avoiding it for genital warts during pregnancy until more is known. During breastfeeding, avoid applying it where a baby's mouth or eyes could touch the skin.
The skin reaction can start after only a few applications, and the treated area will look noticeably red, crusted or raw until it heals. With actinic keratoses, new spots often appear temporarily as the cream reveals damage that was not visible before; this is common, and the full course is still needed even if the area seems clear early. The result is judged a few weeks after treatment ends, once the skin has healed. Results vary. In clinical trials of the 5% cream, about 45% of people with actinic keratoses had no visible patches left 8 weeks after finishing, compared with 3 to 4% using an inactive cream, and about 60% had at least three quarters cleared. Zyclara cleared all patches in about 26% to 46% of people, depending on the trial. New actinic keratoses can form later in sun-damaged skin, so ongoing skin checks and sun protection still matter. For superficial basal cell carcinoma, about 75% of tumors were gone when checked 12 weeks after treatment. Some spots that looked clear still contained cancer cells on closer examination, so a follow-up visit is needed, and a biopsy or another treatment is considered if anything remains. Tell the care team about any new or returning spot in the treated area, even years later. For genital warts, about half of people in the main trial of the 5% cream had complete clearance within 16 weeks, more often women than men, and those who cleared typically did so in around 10 weeks. New warts can appear during or after treatment because the virus can remain in the skin. If warts do not respond, other treatments such as freezing or removal are available.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Imiquimod, what you've noticed, or ask the community a question.